Charumathi Sabanayagam1, Anoop Shankar. 1. Department of Community Medicine, West Virginia University School of Medicine, PO Box 9190, Morgantown, WV 26506-9190, USA.
Abstract
BACKGROUND: Microalbuminuria and plasma homocysteine levels are both considered to be markers of endothelial dysfunction and shown to be predictors of cardiovascular disease (CVD) in epidemiological studies. However, previous studies examining the association between plasma homocysteine and microalbuminuria have suggested that this association is explained by confounding factors such as preexisting CVD, diabetes, hypertension, and reduced kidney function. METHODS: We examined the association between plasma homocysteine and microalbuminuria in a representative sample of US men and women aged ≥ 20 years, who were free of diabetes mellitus, hypertension, and CVD and who participated in the Third National Health and Nutrition Examination Survey (n = 3,948). Microalbuminuria was defined as urinary albumin-to-creatinine ratio ≥ 30 mg/g. RESULTS: Plasma homocysteine levels were positively associated with microalbuminuria in men but not in women (p-interaction <0.0001) after adjusting for age, race/ethnicity, smoking, drinking, body mass index, physical activity, glomerular filtration rate, blood pressure, high-density lipoprotein cholesterol, glycated hemoglobin, serum folate, serum vitamin B(12), and C-reactive protein. In men, the multivariable odds ratio (OR) [95% confidence interval (CI)] of microalbuminuria comparing the highest to the lowest quartile of homocysteine was 5.17 (2.00-13.36); (p-trend = 0.005). Further, men in the highest quartile of homocysteine and age ≥ 60 years had >12-fold odds of microalbuminuria compared with men in the lowest homocysteine quartile and age <60 years. In contrast, in women, the multivariable OR (95% CI) comparing the highest to the lowest quartile of homocysteine was 0.96 (0.86-1.07); (p-trend = 0.41). CONCLUSIONS: Among relatively healthy adults, plasma homocysteine levels are associated with microalbuminuria only in men.
BACKGROUND: Microalbuminuria and plasma homocysteine levels are both considered to be markers of endothelial dysfunction and shown to be predictors of cardiovascular disease (CVD) in epidemiological studies. However, previous studies examining the association between plasma homocysteine and microalbuminuria have suggested that this association is explained by confounding factors such as preexisting CVD, diabetes, hypertension, and reduced kidney function. METHODS: We examined the association between plasma homocysteine and microalbuminuria in a representative sample of US men and women aged ≥ 20 years, who were free of diabetes mellitus, hypertension, and CVD and who participated in the Third National Health and Nutrition Examination Survey (n = 3,948). Microalbuminuria was defined as urinary albumin-to-creatinine ratio ≥ 30 mg/g. RESULTS: Plasma homocysteine levels were positively associated with microalbuminuria in men but not in women (p-interaction <0.0001) after adjusting for age, race/ethnicity, smoking, drinking, body mass index, physical activity, glomerular filtration rate, blood pressure, high-density lipoprotein cholesterol, glycated hemoglobin, serum folate, serum vitamin B(12), and C-reactive protein. In men, the multivariable odds ratio (OR) [95% confidence interval (CI)] of microalbuminuria comparing the highest to the lowest quartile of homocysteine was 5.17 (2.00-13.36); (p-trend = 0.005). Further, men in the highest quartile of homocysteine and age ≥ 60 years had >12-fold odds of microalbuminuria compared with men in the lowest homocysteine quartile and age <60 years. In contrast, in women, the multivariable OR (95% CI) comparing the highest to the lowest quartile of homocysteine was 0.96 (0.86-1.07); (p-trend = 0.41). CONCLUSIONS: Among relatively healthy adults, plasma homocysteine levels are associated with microalbuminuria only in men.
Authors: F Wotherspoon; D W Laight; D L Browne; C Turner; D R Meeking; S E Allard; L J Munday; K M Shaw; M H Cummings Journal: Diabet Med Date: 2006-12 Impact factor: 4.359
Authors: Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-05 Impact factor: 8.860
Authors: S S Soedamah-Muthu; N Chaturvedi; T Teerlink; B Idzior-Walus; J H Fuller; C D A Stehouwer Journal: J Intern Med Date: 2005-11 Impact factor: 8.989
Authors: Mary E J Lott; Julia E Slocomb; Vikram Shivkumar; Bruce Smith; David Quillen; Robert A Gabbay; Thomas W Gardner; Kerstin Bettermann Journal: Acta Ophthalmol Date: 2013-06-07 Impact factor: 3.761